The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

December 2019

Volume 15 Number 12

This issue looks at MR severity as a predictor of therapeutic benefit in TMVI using the Tendyne system; the impact of elevated tricuspid valve inflow gradients after TTVR; TAVI vs SAVR in low surgical risk patients; the ANGIOLITE trial, a first-in-man comparison of the Angiolite SES with an EES in CAD; and an examination of stent thrombosis after endovascular revascularisation of the superficial femoral artery.

Highlights from this issue

Coronary
The ANGIOLITE trial
The ANGIOLITE trial
José Moreu
Moreu J, Moreno-Gómez R, Pérez de Prado A, García del Blanco B, Trillo R, Pinar E, Molina E, Zueco J, Merchán A, Díaz-Fernández J, Amat I
December 20, 2019
DOI: 10.4244/EIJ-D-19-00206